Gain detailed insights into the trading activity of Congress members for JEPI on our government trades page. Stay updated on how elected officials are investing in JEPI.

JEPI - Government Trades

JPMorgan Equity Premium Income ETF

Technology

Industrials

Healthcare

Financial Services

Consumer Defensive

Consumer Cyclical

Utilities

Energy

Communication Services

Real Estate

Basic Materials

Other

The Fund invests in high quality, short-term money marketinstruments which are issued and payable in U.S. dollars

Progressive Corp.

Southern Co.

Trane Technologies Plc Common Stock Usd 1

Abbvie Inc.

Amazon.Com Inc

Meta Platforms, Inc.

Mastercard Inc - A

Microsoft Corp

Intuit, Inc.

Vertex Pharmaceuticals Inc

fed ai

Broad U.S. Equity ETFs

Dividends

Specialty ETFs

Federal Reserve

Trading Ideas

ETFs

AMZN

JEPI

High-yield dividend ETFs are back with Fed&#39;s interest rate cuts. JPMorgan Equity Premium Income has a volatile strategy while Global X Super Dividend offers stability. Choose based on income needs and risk tolerance in a changing economy.

JPMorgan Vs. Global X: Which High-Yield Dividend ETF Is The Better Pick As Fed Cuts Interest Rates?

analyst_ratings_image_8736

Opinion

Markets

General

DIVO

QQQY

SCHD

SPYI

My $100,000 Dividend Portfolio Decision — JEPI, SPYI, Or XYLD

JPMorgan Photo by Katherine Welles on Shutterstock

Equities

Large Cap

News

Media

iShares Trust Dow Jones US Financial Services Index Fund

JEPQ

TSX:JEPI

TSX:JEPQ

JPMorgan Asset Management expands Canadian business with launch of 2 active ETFs, providing access to global investment strategies.

J.P. Morgan Launches New ETFs, Plans To Add Jobs In Canada

regularguy-eth-w9coDxtsfts-unsplash

MSFT

Predictable Portfolio Income During Unpredictable Times: My Favorite High-Income ETF That Pays Me Every Single Month

XYLD

Introduction

2023 was a year that took many by surprise, including myself.

JEPI: Do Not Make The Same Mistake Two Years In A Row, Buy This Covered Call ETF Instead

AAPL

AVGO

NVDA

QQQI

QYLD

TSLA

A few months ago, I analyzed the total performance of the three most popular S&amp;P 500 covered call ETFs in 2023: the JPMorgan Equity Premium Income ETF (ARCA: JEPI), the GlobalX S&amp;P500 Covered Call ETF (ARCA: XYLD), and the NEOS S&amp;P 500 High Income ETF (BATS: SPYI). 

QQQI: The Undiscovered Nasdaq-100 Covered Call ETF You&#39;ve Been Looking For (14.4% Distribution Yield)

Ai Processor

Tech

JPST

JPMorgan&#39;s AI-powered tool, Cash Flow Intelligence, has greatly reduced manual labor for corporate clients. The bank may introduce fees for this service as part of its plan to integrate AI into its operations. Other banks, such as Morgan Stanley, Goldman Sachs, and Citigroup, have also implemented AI in their operations. JPMorgan&#39;s stock price rose 0.52% on Monday. 

JPMorgan Uses AI To Cut Down On Manual Labor: How Dimon&#39;s Bank Leverages Tech (CORRECTED)

Long Ideas

HTGC

TOST

On CNBC’s &#34;Halftime Report Final Trades,&#34; Jenny Harrington of Gilman Hill Asset Management named  Hercules Capital, Inc. (NYSE: HTGC)  as her 

General Motors, Hercules Capital, Toast And More: CNBC&#39;s &#39;Final Trades&#39;


	The JPMorgan Equity Premium Income ETF (ARCA: JEPI) provides their investors with consistent monthly income and lower volatility. 
	During times of immense bullishness, JEPI fails to capture even a fraction of total return against their benchmark index. 


JEPI: No Longer An Income-Focused Investor&#39;s Only Holdings, It&#39;s Time To Play Offense

It’s been six months since I first began researching the NEOS S&amp;P 500 High Income ETF (BATS: SPYI) — continuously benchmarking its performance against the JPMorgan Equity Premium ETF (ARCA: JEPI).

SPYI: The New High-Income ETF That Is Outperforming Both JEPI And XYLD Thus Far In 2023

O'Reilly Automotive's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NYSE">ORLY</a>) short percent of float has fallen 19.31% since its last report. The company recently reported that it has 935 thousand shares sold short, which is 1.63% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>O'Reilly Automotive Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732194912_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for O'Reilly Automotive has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing O'Reilly Automotive's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, O'Reilly Automotive's peer group average for short interest as a percentage of float is 11.82%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

ORLY

How Is The Market Feeling About O'Reilly Automotive?

Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), an advanced nuclear technology company, announced today that Atomic Alchemy Inc. (Atomic Alchemy), which Oklo has proposed to acquire through an all-stock transaction, has signed a Memorandum of Understanding (MOU) with Zeno Power Systems, Inc. (Zeno Power), a leading developer of commercial Radioisotope Power Systems (RPSs). Zeno Power's innovative power systems convert heat from radioisotopes into a reliable and consistent supply of clean energy for commercial and government customers in critical environments across space and terrestrial markets.
This MOU marks a key step in Atomic Alchemy's strategy to provide to the growing radioisotope market and expand its impact on critical missions, including space exploration and national defense. The MOU also represents an important milestone in furthering Atomic Alchemy's efforts to supply radioisotopes for non-medical applications and its goal to expand its presence in key markets such as defense and energy. Atomic Alchemy and Zeno Power expect to explore opportunities that build upon Atomic Alchemy's expertise in radioisotope production and recovery.
Through this collaboration, Atomic Alchemy expects to supply Zeno Power with strontium-90 (Sr-90), americium-241 (Am-241), and other radioisotopes needed to power RPSs like Radioisotope Thermoelectric Generators, or "nuclear batteries." These systems are designed for remote and off-grid environments, such as space and undersea applications. These radioisotopes can be produced as coproducts from Oklo's recycling processes.

OKLO

Atomic Alchemy, Oklo's Proposed Acquisition Target, Signs MOU With Zeno Power To Provide Fuel For Commercial Radioisotope Power Systems

Editor&#8217;s Note: The story has been updated to mention the quantity of restricted stock purchased by the CEO
On Thursday, Worksport Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) announced that it has retained Digital BD, Inc to monitor and investigate potentially illegal short-selling activity of its stock.
Rossi said the recent stock trading activity must reflect the business&#8217; health or significant growth pathways.
He said that the company sets new volume sales records almost daily while facing suspicious and volatile stock activity that it proposes to investigate thoroughly.
The company reported a 581% growth<a target="_blank" href="https://www.globenewswire.com/news-release/2024/11/13/2980701/0/en/Worksport-WKSP-Reports-Significant-581-YoY-Revenue-Growth-in-Q3-2024-Eyes-Record-2025.html" rel="noreferrer noopener">&nbsp;</a>in the third quarter and expects the 2025 revenue to exceed its market capitalization as of Wednesday. The sales are growing exponentially monthly, and three highly innovative products are set for near-term release, Rossi added.
Concurrently, CEO Steven Rossi has purchased 33,333 restricted Worksport shares at a 44% premium to the market price at $0.75 per share on November 19th.
Worksport has engaged&nbsp;Digital BD, a provider of&nbsp;Regulation SHO compliance monitoring, short sale trading analytics, and market integrity surveillance to safeguard shareholder value and address unusual trading patterns.
Digital BD will monitor daily short volume data from all U.S. exchanges, encompassing EXEMPT and&nbsp;NON-EXEMPT short sales, and will report its findings to the company.
Digital BD will scrutinize market makers trading&nbsp;Worksport shares daily for adherence to fair market-making requirements.
The Securities and Exchange Commission specifies that bona-fide market-making does not include activities related to speculative selling strategies for investment purposes that are disproportionate to usual market-making patterns.
Rossi expressed commitment to continuing its growth trajectory and protecting the interests of our shareholders.&nbsp;With the assistance of Digital BD, the company proposed to closely monitor trading activities to ensure compliance with all legal requirements.
CEO Rossi said Worksport as significantly undervalued and expects to unlock its true value. He also looks to discover, eliminate, and do everything possible to prevent future illegal short selling or open market manipulation of Worksport&#8217;s stock.
Worksport&#8217;s <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41953667/exclusive-worksports-q3-revenue-soars-581-as-new-product-lines-boost-growth-raises-2025-outlook" rel="noreferrer noopener">third-quarter revenue</a> reached $3.12 million, up by 581% year-over-year.
Price Action: WKSP stock traded higher by 5.42% to $0.53 premarket at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42098028/qualcomms-shift-from-handsets-to-ai-and-automotive-wins-analysts-confidence" target="_blank" rel="noreferrer noopener">Qualcomm&#8217;s Shift From Handsets To AI And Automotive Wins Analysts&#8217; Confidence</a></li>
</ul>

Legal

Exclusives

WKSP

EXCLUSIVE: Worksport Ropes In Digital BD to Probe Short Selling, CEO Buys Stock At Premium (UPDATED)

Mizuho analyst Salim Syed maintains Nkarta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTX#NASDAQ">NKTX</a>) with a Outperform and lowers the price target from $20 to $16.

Price Target

Analyst Ratings

NKTX

Mizuho Maintains Outperform on Nkarta, Lowers Price Target to $16

WIIM

SPAI

Safe Pro shares are trading higher after the company announced it entered into an MOU with a U.S. prime contractor for a purchase order for real-world landmine and unexploded ordnance imagery.

WORX

SCWorx shares are trading higher after the company announced it regained Nasdaq compliance requirements regarding its periodic reporting.

Intensity Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 1,237,113 shares of its common stock in a registered direct offering at a purchase price of $2.425 per share.
In a concurrent private placement (the "Private Placement" and together with the Registered Offering, the "Offerings"), the Company also agreed to issue to the same investor warrants to purchase up to 1,237,113 shares of its common stock (the "Common Warrants"). The Common Warrants have an exercise price of $2.95 per share, will be exercisable commencing six months from the date of issuance, and will expire five and one-half years following the date of issuance.
The gross proceeds from the Offerings, before deducting the placement agent's fees and other offering expenses payable by the Company, are expected to be approximately $3 million. The Company expects to use the net proceeds from the Offerings for general working capital.
A.G.P./Alliance Global Partners is acting as lead placement agent for the Offerings and Brookline Capital Markets, a division of Arcadia Securities, LLC, is acting as a co-placement agent for the Offerings. &nbsp;
The Offerings are expected to close on or about November 22, 2024, subject to the satisfaction of customary closing conditions.

Offerings

INTS

Intensity Therapeutics Announces Pricing Of $3M Registered Direct Offering With A Single Healthcare Focused Institutional Investor For The Issuance And Sale Of 1,237,113 Shares Of Its Common Stock In A Registered Direct Offering At A Purchase Price Of $2.425 Per Share And Concurrent Private Placement

Mizuho analyst Salim Syed maintains Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Outperform and raises the price target from $90 to $100.

GILD

Mizuho Maintains Outperform on Gilead Sciences, Raises Price Target to $100

EVLV

Evolv Technology Reports Q3 Highlights: Over 2B Visitors Screened Since Inception, 465 New Multi-Year Subscriptions, Expansion To 1,100 School And 400 Hospital Buildings, Adds 3 Pro Sports Stadiums And 3 Fortune 500 Customers, With Daily Screening Of 3M Visitors And Tagging 500+ Firearms

MRUS

Merus shares are trading higher after Goldman Sachs initiated coverage on the stock with a Buy rating and announced a $73 price target.

Mizuho analyst Salim Syed maintains Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Outperform and raises the price target from $99 to $103.

CYTK

Mizuho Maintains Outperform on Cytokinetics, Raises Price Target to $103

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">49.8000</td>
<td align="right">0.260</td>
<td align="right">0.52</td>
<td>138.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">139.5500</td>
<td align="right">0.600</td>
<td align="right">0.43</td>
<td>1.7 million</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">80.3600</td>
<td align="right">0.140</td>
<td align="right">0.17</td>
<td>2.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">215.0000</td>
<td align="right">0.380</td>
<td align="right">0.17</td>
<td>280</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">143.0900</td>
<td align="right">0.210</td>
<td align="right">0.14</td>
<td>8.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">231.3500</td>
<td align="right">0.220</td>
<td align="right">0.09</td>
<td>27.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">43.5000</td>
<td align="right">0.030</td>
<td align="right">0.06</td>
<td>451</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">80.5392</td>
<td align="right">0.049</td>
<td align="right">0.06</td>
<td>3.9K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">96.22</td>
<td align="right">-0.12</td>
<td align="right">-0.13</td>
<td>27.6K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For November 21, 2024

Stock Split

APLM

Apollomics Announces 1-For-100 Reverse Share Split Effective November 25, 2024, With Trading On A Split-Adjusted Basis Under Existing Symbol APLM

AIRE

reAlpha Acquires USRealty

Mizuho analyst Salim Syed maintains Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Outperform and lowers the price target from $251 to $207.

BIIB

Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207

RLYB

Rallybio Initiates Phase 2 Trial Of RLYB212 To Address HPA-1a Alloimmunization And FNAIT In Pregnant Women, With Screening Underway Across European Sites For Target Enrollment Of Eight Participants

ExxonMobil Announces $200M Investment To Expand Advanced Recycling Operations In Texas, Targeting 1 Billion Pounds Annual Capacity By 2027 With Additional Units Planned Globally

Moody's Acquires Numerated Growth Technologies, Terms Not Disclosed

Goldman Sachs analyst Toshiya Hari maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and raises the price target from $150 to $165.

Goldman Sachs Maintains Buy on NVIDIA, Raises Price Target to $165

ASST

NFLX

Asset Entities Partners With Netflix Star Jas Leverette To Launch Subscription-Based Digital Dog Training Community On Discord, Featuring Training From Cali K9 Team

Is It Time To Sell Volatility?

Election-Ready: Why JEPI's 7% Yield Deserves Your Vote Now

EOI: Attractive Distribution And Track Record, But Shallow Discount Persists

5 ETFs To Retire With In 2025

2% CPI is a headline you won't find in today's Wall Street Journal. The reason is that official inflation gauges, such as CPI, are in the mid to upper 2% range.

2% CPI Is Here

My 9.5% Income Portfolio CEFs And Classic Cars

JEPQ And Its Place In An Income Portfolio

The Only Time To Buy This 10% Yield: JEPQ

How You Could Retire With $1 Million In 2025

GPIX: Income Play On The S&P 500 That Can Outperform

ACWV

AMZY

ARCC

CCAP

CLOI

FDUS

FEPI

GPIX

JAAA

JBBB

PUTW

RYLD

SGOV

SPXX

SPYD

TBIL

USMV

USOI

XFLT


Max MillerHouse (R-OH)	$1K - $15K	etf	Sale (Partial)	Oct 08, 2023	Oct 06, 2023	House
Kevin HernHouse (R-OK)	$1K - $15K	etf	Purchase	Nov 09, 2022	Oct 06, 2022	House
Kevin HernHouse (R-OK)	$1K - $15K	etf	Purchase	Oct 10, 2022	Sep 07, 2022	House

Government Trades

JPMorgan Equity Premium Income ETF

top performing JEPI trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga